Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilko Weichert

Showing results (471-480 of 504) with videos related to

Pageof 51
Sort By:
Nature Cancer|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinomaMelissa Barroux, Jacob Househam, Eszter Lakatos, et al.
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trialsSonia L Villegas, Valentina Nekljudova, Nicole Pfarr, et al.
Cancer & Metabolism|December 10, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinomaIrina Heid, Corinna Münch, Sinan Karakaya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyAlbrecht Stenzinger, Volker Endris, Jan Budczies, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
Cancer Discovery|July 20, 2021
Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary CancerChiara Falcomatà, Stefanie Bärthel, Angelika Ulrich, et al.
International Journal of Cancer|October 14, 2021
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapyBouchra Tawk, Ute Wirkner, Christian Schwager, et al.
International Journal of Cancer|May 29, 2019
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancerKatrin Schmitt, Britta Molfenter, Natalia Koerich Laureano, et al.
Pageof 51

Showing results (471-480 of 504) with videos related to

Sort By:
Pageof 51
Nature Cancer|May 14, 2025
Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of esophageal adenocarcinomaMelissa Barroux, Jacob Househam, Eszter Lakatos, et al.
International Journal of Cancer|June 10, 2017
Precision oncology based on omics data: The NCT Heidelberg experiencePeter Horak, Barbara Klink, Christoph Heining, et al.
Nature Medicine|February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaElisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2021
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trialsSonia L Villegas, Valentina Nekljudova, Nicole Pfarr, et al.
Cancer & Metabolism|December 10, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinomaIrina Heid, Corinna Münch, Sinan Karakaya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology StudyAlbrecht Stenzinger, Volker Endris, Jan Budczies, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
Cancer Discovery|July 20, 2021
Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary CancerChiara Falcomatà, Stefanie Bärthel, Angelika Ulrich, et al.
International Journal of Cancer|October 14, 2021
Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapyBouchra Tawk, Ute Wirkner, Christian Schwager, et al.
International Journal of Cancer|May 29, 2019
Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancerKatrin Schmitt, Britta Molfenter, Natalia Koerich Laureano, et al.
Pageof 51